Zobrazeno 1 - 10
of 481
pro vyhledávání: '"J. Jozefonvicz"'
Autor:
J. Danon, J. Jozefonvicz
Publikováno v:
Journal of Polymer Science Part C: Polymer Symposia. 30:57-67
Autor:
J. Jozefonvicz, M. Jozefowicz
Publikováno v:
ChemInform. 24
Bioactive biomaterials made of synthetic or artificial polymers substituted with specific chemical functional groups carried by the macromolecular chain are designed to develop specific interactions with living systems. These soluble or insoluble pol
Autor:
J. Jozefonvicz, M. Jozefowicz
Publikováno v:
Pure and Applied Chemistry. 64:1783-1788
Bioactive biomaterials made of synthetic or artificial polymers substituted with specific chemical functional groups carried by the macromolecular chain are designed to develop specific interactions with living systems. These soluble or insoluble pol
Publikováno v:
Journal of Materials Science: Materials in Medicine. 2:193-196
Human procoagulant factor VIII (FVIII:C), is a protein that participates in the cascade of blood coagulation. It is absent or defective in haemophiliac A patients. Furthermore, about 5%–10% of severely affected patients who have received FVIII conc
Publikováno v:
Journal of Chromatography A. 510:71-81
In order to prepare easily derivatizable supports for high-performance affinity chromagtograhy (HPAC), the advantages of traditional polysaccharide-based supports were combined with the excellent mechanical properties of silica by coating the porous
Autor:
C, Boisson-Vidal, M, Haouam, H, Lakhiari, H, Huguet, L, Dahri, Y, Sultan, J, Jozefonvicz, R, Siali
Publikováno v:
Vox sanguinis. 83(3)
This article presents a new approach for removing the Factor VIII inhibitors (anti-FVIII) in haemophiliac patients by immunoadsorption using an affinity matrix.Ten blood samples from haemophiliac patients with anti-FVIII were assayed for antibodies,
Breast carcinoma cell uptake and biodistribution of technetium-99m-carboxymethyl benzylamide dextran
Publikováno v:
Anticancer research. 21(1A)
Carboxymethyl Benzylamide Dextran (CMDB7) displayed an in vitro growth inhibitory activity on breast tumor cells. CMDB7 is able to disrupt the interaction of angiogenic growth factors (FGF2, TGF beta and PDGF) with their membrane receptors. This comp
Autor:
R, Bagheri-Yarmand, Y, Kourbali, A M, Rath, R, Vassy, A, Martin, J, Jozefonvicz, C, Soria, H, Lu, M, Crépin
Publikováno v:
Cancer research. 59(3)
We previously showed that carboxymethyl benzylamide dextran (CMDB7) prevents tumor growth and tumor angiogenesis by binding to angiogenic growth factors, thereby preventing them from reaching their receptors on tumor or stromal cells (Bagheri-Yarmand
Publikováno v:
Cell growthdifferentiation : the molecular biology journal of the American Association for Cancer Research. 9(6)
The highly tumorigenic human breast cancer MCF-7ras line (Ha-ras-transfected MCF-7 cell line) loses estrogen dependence and secretes diffusible growth factors that support its own tumor growth in vivo. Our previous studies showed that carboxymethyl b